End-of-life targeted degradation of DAF-2 insulin/IGF-1 receptor promotes longevity free from growth-related pathologies.
生命末期靶向降解 DAF-2 胰岛素/IGF-1 受体可促进长寿，且不引起与生长相关的病理
期刊:Elife
影响因子:6.4
doi:10.7554/eLife.71335
Venz Richard, Pekec Tina, Katic Iskra, Ciosk Rafal, Ewald Collin Yvès
